West Pharmaceutical Services Inc (WST)
Return on assets (ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 593,400 | 559,400 | 518,700 | 552,100 | 585,900 | 630,600 | 685,600 | 684,400 | 661,800 | 612,500 | 519,200 | 423,100 | 346,200 | 311,700 | 285,700 | 260,600 | 241,700 | 229,800 | 228,700 | 218,700 |
| Total assets | US$ in thousands | 3,829,500 | 3,754,700 | 3,669,600 | 3,723,600 | 3,616,800 | 3,316,800 | 3,361,700 | 3,294,700 | 3,313,800 | 3,142,600 | 2,933,500 | 2,739,700 | 2,793,800 | 2,582,800 | 2,392,300 | 2,246,500 | 2,341,400 | 2,174,000 | 2,123,200 | 2,036,200 |
| ROA | 15.50% | 14.90% | 14.14% | 14.83% | 16.20% | 19.01% | 20.39% | 20.77% | 19.97% | 19.49% | 17.70% | 15.44% | 12.39% | 12.07% | 11.94% | 11.60% | 10.32% | 10.57% | 10.77% | 10.74% |
December 31, 2023 calculation
ROA = Net income (ttm) ÷ Total assets
= $593,400K ÷ $3,829,500K
= 15.50%
The return on assets (ROA) for West Pharmaceutical Services, Inc. has shown a gradual decline over the past four quarters, starting at 16.20% in Q4 2022 and reaching 15.50% in Q4 2023. This decreasing trend indicates a potential decrease in the company's ability to generate profits relative to its total assets. Despite the decline, West Pharmaceutical Services, Inc. has maintained a relatively strong ROA throughout the period, consistently above 14%. The company's ROA peaked at 20.77% in Q1 2022, indicating a period of exceptionally high profitability relative to its asset base. Overall, while the recent trend shows a slight decrease, West Pharmaceutical Services, Inc. continues to efficiently utilize its assets to generate profits.
Peer comparison
Dec 31, 2023